US Pharma MarketingThe post Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses appeared first on Clinical Trials Arena.
Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses
Azafaros has completed patient recruitment for its Phase III study assessing nizubaglustat for GM1/GM2 gangliosidoses. The post Azafaros concludes Phase III trial recruitment for GM1/GM2 gangliosidoses appeared first on Clinical Trials Arena .
Azafaros has completed patient recruitment for its Phase III study assessing nizubaglustat for GM1/GM2 gangliosidoses.
Source: Clinical Trials Arena